Life-Sciences-Scandinavia.com
The Nordic Life Sciences Web Portal

This is a free web portal for the life sciences in the Nordic countries Denmark, Finland, Iceland, Norway and Sweden... » read more

Recipharm: Marc Funk Moves to BoD; Greg Behar New CEO (2023-11-21)
Recipharm, a leading, global player in the pharmaceutical CDMO industry, announces today the appointment of Greg Behar as Chief Executive Officer. Marc Funk, who successfully led Recipharm into its next phase of growth, will join the Board of Directors, where he wi...
InDex Pharmaceuticals Discontinues Cobitolimod Phase 3 (2023-11-21)
> Independent Data Monitoring Committee (DMC) advises that cobitolimod is unlikely to meet the primary endpoint upon completion of Induction Study 1 > More information regarding next steps will be provided once a thorough analysis of the data from Induction Stud...
NMD Pharma Raises €75m Series B Led by Jeito Capital (2023-11-15)
> Proceeds will be used to complete three Phase 2 clinical studies of first-in-class ClC-1 molecule inhibitor NMD670 in myasthenia gravis, spinal muscular atrophy and Charcot-Marie-Tooth disease > In addition, NMD Pharma will continue to mature and expand its p...
Bico Has Divested Ginolis via MBO for €1 to Current CEO (2023-11-13)
BICO has divested Ginolis through a management buy-out to Ginolis’ current CEO Kauko Väinämö. The purchase price amounted to €1. The transaction is estimated to result in a divestment loss of SEK -25m, which is a non-cash item. Final divestment result will be repor...
Maria Forss Assumes Office as Bico’s CEO on 20 November (2023-11-13)
Maria Forss assumes office on November 20, 2023, and to ensure a seamless transition, Erik Gatenholm will during a quarter assist with her onboarding process. Thereafter, he will transition into the role as a senior advisor to BICO. Erik Gatenholm’s remuneration...
VectorY Raises €129m Series A Led by EQT LS & Forbion (2023-11-13)
> Round co-led by EQT Life Sciences and Forbion > Series A financing will support clinical development of the lead program in Amyotrophic Lateral Sclerosis (ALS), and preclinical development of pipeline programs based on VectorY’s broad technology platform > ...
Kynexis Launches with €57m Series A & License from MTPC (2023-11-07)
> Lead Candidate KYN-5356, a First-In-Class Small Molecule KAT-II Inhibitor, Advancing Toward the Clinic for Cognitive Impairment Associated With Schizophrenia > €57 Million Series A Led by Forbion > Kees Been Joins as Chief Executive Officer and Jens Wendlan...
Nanoform Grants Global Starmap AI License to AstraZeneca (2023-10-23)
Nanoform Finland Plc. (Nanoform), an innovative nanoparticle medicine-enabling company today announced that it has granted AstraZeneca Plc a global online STARMAP® license. STARMAP® is a digital AI version of the CESS® technology that enables in-silico experiments ...
HTGF: FarmInsect Raises €8m Series A Led by Sandwater (2023-10-23)
> Agritech start-up FarmInsect has successfully completed an oversubscribed Series A financing round, raising a total of € 8 million. > The round was led by Sandwater with participation from Bayern Kapital, Australia’s Minderoo Foundation, and the EIC fund, wi...
Thermo Fisher Scientific to Acquire Olink for $3.1b in Cash (2023-10-17)
> Enhances Thermo Fisher’s Capabilities in the High-Growth Proteomics Market with the Addition of Highly Differentiated Solutions > Complements Existing Life Sciences and Mass Spectrometry Offerings, Accelerating Protein Biomarker Discovery and Providing Strong ...

Life-Sciences-Scandinavia.com is your doorway to the Nordic life sciences!

[LSS] provides free, up-to-date and structured access to

– News
– Products
– Persons
– Organisations
– Financings
– Collaborations

in the Scandinavian countries Denmark, Finland, Iceland, Norway and Sweden.

Access is unrestricted and free, requiring no log in and no user registration.The high-quality content is not related to the advertising, with topical relevance being the criterion for inclusion. [LSS] is 100% Made in Germany!

» Start here with the latest News!

Picture EBD Group World of Partnering Opportunities 650x200px

To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Please visit also our web portals for the life sciences in German-speaking Europe (DE, AT & CH) and the worldwide mass spectrometry industry at Life-Sciences-Germany.com (life sciences in German-speaking Europe) and Mass-Spec-Capital.com (worldwide mass spectrometry)